Home sleep testing device and service provider Itamar Medical Ltd and sleep equipment sanitizer maker SoClean Inc have entered into a collaboration agreement between their respective wholly owned subsidiaries to make Itamar Medical’s WatchPAT ONE home sleep apnea test and digital health services available to consumers. The collaboration is designed to overcome the barriers to sleep apnea testing and therapy solutions by enabling consumers to purchase remote sleep consultations and home-based sleep test using the WatchPAT ONE in the comfort of their own homes.
WatchPAT ONE is an FDA cleared disposable home sleep test. WatchPAT ONE provides an automated sleep report for interpretation.
Under the terms of the collaboration agreement, SoClean’s subsidiary will have exclusivity to market and sell the WatchPAT ONE to the DTC Segment in the United States, subject to purchasing certain minimum quantities. SoClean will have exclusive DTC rights in the United States through any and all marketing and sales channels, excluding healthcare providers and facilities and SoClean parent company has agreed to guarantee the performance of the collaboration by its subsidiary. SoClean plans to announce further details regarding its home sleep apnea testing service in Q1 2020.
